All Viruses articles – Page 5
-
NewsChildren surpass a year of HIV remission after treatment pause
Four children have remained free of detectable HIV for more than one year after their antiretroviral therapy (ART) was paused to see if they could achieve HIV remission.
-
NewsBreakthrough discovery will improve medical monitoring, preventive care for elephants
Researchers have found that population-based reference values for blood cell counts are not sensitive enough to detect critical deviations that frequently occur with active Elephant Endotheliotropic Herpesvirus infection.
-
NewsScientists report positive immune response against mpox using a vaccine
Scientists at one of the largest cancer research and treatment organizations in the United States show that its COVID-19 vaccine also protects against mpox.
-
NewsStudy shows new class of antivirals that works against SARS-CoV-2
Researchers have uncovered a new class of drugs with the potential to prevent or treat infections in a future viral outbreak.
-
NewsZika vaccine safe, effective when administered during pregnancy
A vaccine against Zika virus is safe and effective when administered both before and during pregnancy, according to new research.
-
NewsSpecial insecticide paint may help curb zika and dengue fever outbreaks
Scientists showed that insecticide paint could effectively decrease mosquito presence in Cabo Verde (Cape Verde) for up to one year, making this paint a potential strategy to decrease the transmission of vector-borne diseases.
-
NewsMicrobial viruses act as secret drivers of climate change
In a new study, scientists have discovered that viruses that infect microbes contribute to climate change by playing a key role in cycling methane, a potent greenhouse gas, through the environment.
-
NewsResearchers uncover how virus causes cancer, point to potential treatment
Kaposi sarcoma-associated herpesvirus activates a specific pathway to drive viral persistent infection and cell growth, paving the way for tumors to form.
-
NewsNew antibodies target “dark side” of influenza virus protein
Researchers have identified antibodies targeting a hard-to-spot region of the influenza virus, shedding light on the relatively unexplored “dark side” of the neuraminidase (NA) protein head.
-
NewsThe future is personalised care for influenza and flu-like illness
A new research review will focus on a future of more personalised care for diseases such as influenza, so that patients and doctors will be able to more accurately determine when the infectious part of the illness has passed.
-
NewsResearchers reveal how the SARS-CoV-2 virus acquires its spherical shape
Researchers report that when the M protein, which is adjacent to the spike protein on SARS-CoV-2, gets lodged in the membrane, it coaxes the membrane to curve by locally reducing the membrane thickness.
-
NewsVaping can increase susceptibility to infection by SARS-CoV-2
Vapers are susceptible to infection by SARS-CoV-2, the virus that spreads COVID-19 and continues to infect people around the world, a new study has found.
-
NewsBCG mechanism extends protection to beat influenza A
A new study uncovered a previously unknown mechanism that extends the BCG vaccine’s shield to combat influenza A virus—the most prevalent flu strain.
-
NewsFusion protein reveals a conservative antigenic domain across herpesviruses
A new study proposes that the gB DII domain within the herpesvirus family constitutes a broadly conserved neutralizing epitope structural domain.
-
NewsSpace-grown antiviral drug successfully brought back to earth in private Varda Space capsule
Space-grown crystals of an antiviral drug have been brought to earth following the successful recovery of the capsule from Varda Space Industries’ W-1 mission.
-
News‘Dynamic duo’ defences in bacteria ward off viral threats
Scientists have discovered that bacteria can pair up their defence systems to create a formidable force, greater than the sum of its parts, to fight off attack from phage viruses.
-
FeaturesUnder the microscope: Alaskapox
Alaskapox virus (AKPV) is genetically more similar to old world than new world Orthopoxvirus.
-
NewsComplement system response to AAV vector gene therapy
Recent clinical trials utilizing high doses of adeno-associated virus (AAV) vectors have highlighted a new challenge to AAV gene transfer – activation of the complement system.
-
NewsStudy examines medical mystery of child hepatitis outbreak
A study into an unexpected wave of severe hepatitis cases in 2022 supports the theory that it was caused by an infection of different viruses at the same time, but also reveals cases were higher and more severe than initially thought.
-
NewsStudy of usefulness of lockdowns during epidemics identifies alternate solution
Researchers found that small nonpharmaceutical interventions can tip the optimal response between very different approaches to slowing viral spread and identified an alternate approach that has previously not been recognized as effective.
